Mersana Therapeutics CEO and leadership

Ms. Anna Protopapas is a Chief Executive Officer at MERSANA THERAPEUTICS, INC. and is based in United States.

Ms. Carvajal was most recently the Chief Legal Officer, General Counsel & Secretary at Momenta Pharmaceuticals, where she led the company’s legal operations through both business restructuring and the successful acquisition by Johnson & Johnson for $6.5 billion. She also served as a key strategic legal partner in the Company’s financing, business development and contractual decision-making efforts. Prior to joining Momenta, Ms. Carvajal served as the Vice President, General Counsel at Cerulean Pharma. Previously, Ms. Carvajal worked at Millennium Pharmaceuticals in several positions of increasing seniority, where she was the legal business partner to Millennium’s R&D, business development, manufacturing and commercial functions. Ms. Carvajal also held positions earlier in her career at law firms Day, Berry & Howard LLP and Hill & Barlow. She received her Juris Doctorate with honors from the Georgetown University Law Center and holds a bachelor’s degree with honors from Harvard University. She is a member of the Commonwealth of Massachusetts Bar.

Ms. Anna Protopapas is a Chief Executive Officer at MERSANA THERAPEUTICS, INC. and is based in United States.